Determination of diclofenac in pharmaceutical preparations by voltammetry and gas chromatography methods  by Yilmaz, Bilal & Ciltas, Ulvihan
H O S T E D  B Y Contents lists available at ScienceDirect
www.elsevier.com/locate/jpa
Journal of Pharmaceutical Analysis
Journal of Pharmaceutical Analysis 2015;5(3):153–1602095-1779 & 2014 Xi’
NC-ND license (http:/
http://dx.doi.org/10.10
nCorresponding aut
E-mail address: yi
Peer review under rwww.sciencedirect.comORIGINAL ARTICLEDetermination of diclofenac in pharmaceutical
preparations by voltammetry and gas
chromatography methods
Bilal Yilmazn, Ulvihan CiltasDepartment of Analytical Chemistry, Faculty of Pharmacy, Ataturk University, 25240 Erzurum, TurkeyReceived 22 July 2014; revised 2 October 2014; accepted 15 October 2014
Available online 28 October 2014KEYWORDS
Diclofenac;
Sweep voltammetry;
Chromatography–mass
spectrometry;
Pharmaceutical
preparationan Jiaotong Univers
/creativecommons.o
16/j.jpha.2014.10.0
hor. Tel.: þ90 4422
lmazb@atauni.edu.tr
esponsibility of Xi’Abstract Rapid, sensitive and speciﬁc methods were developed for the determination of diclofenac in
pharmaceutical preparations by linear sweep voltammetry (LSV) and gas chromatography (GC) with
mass spectrometry (MS) detection. The linearity was established over the concentration range of 5–
35 μg/mL for LSV and 0.25–5 μg/mL for GC–MS method. The intra- and inter-day relative standard
deviation (RSD) was less than 4.39% and 4.62% for LSV and GC–MS, respectively. Limits of
quantiﬁcation (LOQ) were determined as 4.8 and 0.15 μg/mL for LSV and GC–MS, respectively. No
interference was found from tablet excipients at the selected assay conditions. The methods were
applied for the quality control of commercial diclofenac dosage forms to quantify the drug and to check
the formulation content uniformity.
& 2014 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Diclofenac is a nonsteroidal anti-inﬂammatory drug (NSAID)
that is widely prescribed for the treatment of rheumatoid
arthritis, osteoarthritis, musculoskeletal injuries and post-sur-
gery analgesia in human and veterinary medicine [1]. Patients
are frequently given special formulations of diclofenac or a co-
treatment agent as a therapeutic strategy to attenuate the
gastrointestinal tract complications that limit the use ofity. Production and hosting by Elsevie
rg/licenses/by-nc-nd/3.0/).
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315200; fax: þ90 4422315201.
(B. Yilmaz).
an Jiaotong University.diclofenac and other NSAIDs [2,3]. Many patients prescribed
diclofenac for arthritis also take additional drugs for other
chronic health problems such as hypertension [4].
To date, several methods for the determination of diclofenac
have been reported. These include potentiometry [5–7], capillary
zone electrophoresis [8], high-performance liquid chromatography
(HPLC) [9–11], high-performance liquid chromatography–mass
spectrometry (HPLC–MS) [12], spectrophotometry [13,14], spec-
troﬂuorometry [15,16], thin layer chromatography [17], gas
chromatography [18], polarographic analysis [19], and spectro-
scopic methods [20–24]. An extensive literature survey revealed
that there were several HPLC methods for the determination of
diclofenac in blood plasma, whereas there was little other work
disclosed only for the quantitative determination of diclofenac inr B.V. All rights reserved. This is an open access article under the CC BY-
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were inﬂuenced by interference of endogenous substances and
potential loss of drugs in the re-extraction procedure and involving
lengthy, tedious and time-consuming plasma sample preparation
and extraction processes and requiring a sophisticated and
expensive instrumentation.
On extensive survey of literature, no LSV method was
reported till date for determination of diclofenac in pure and
pharmaceutical dosage forms. The development of a new method
capable of determining drug amount in pharmaceutical dosage
forms is important. Electroanalytical techniques have been used
for the determination of a wide range of drug compounds with
the advantages that there is, in most instances, no need for
derivatization and that these techniques are less sensitive to
matrix effects than other analytical techniques. Additionally,
application of electrochemistry involves the determination of
electrode mechanism. Redox properties of drugs can give
insights into their metabolic fate or their in vivo redox processes
or pharmacological activity [25–28]. Despite the analytical
importance of the electrochemical behavior and oxidation
mechanism of diclofenac, no report has been published on the
voltammetric study of the electrochemical oxidation of diclofe-
nac in nonaqueous media. It is well known that the experimental
and instrumental parameters directly affect the electrochemical
process and voltammetric response of drugs. Consequently, it
would be interesting to investigate the oxidation process of
diclofenac in aprotic media.
Therefore, this paper describes a new LSV method for
determination of diclofenac and a gas chromatography with MS
detection. The LSV method was aimed at developing an easy and
rapid assay method for diclofenac without any time-consuming
sample preparation steps for routine analysis. GC method was
attempted to demonstrate the utility of MS detection for determi-
nation of diclofenac with simple sample preparation and reason-
able analysis time with high precision. In both the proposed
methods, there is no need to extract the drug from the formulation
excipient, thereby decreasing the error in quantization. Formula-
tion samples can be directly used after dissolving and ﬁltration.
The developed methods were used to determine the total drug
content in commercially available tablets of diclofenac.2. Materials and methods
2.1. Chemicals
Diclofenac was obtained from Sigma (St. Louis, MO, USA).
Acetonitrile and lithium perchlorate (LiClO4) were purchased
from Fluka (Buchs, Switzerland). Diclomec, Dicloﬂam and
Voltaren tablets were obtained from pharmacies (Erzurum,
Turkey).
2.2. Voltammetric and chromatographic system
Electrochemical experiments were performed on a Gamry
Potentiostat Interface 1000 controlled with software PHE
200 and PV 220. All measurements were carried out in a
single-compartment electrochemical cell with a standard three-
electrode arrangement. A platinum disk with an area of
0.72 cm2 and a platinum wire were used as the working and
the counter electrodes, respectively. The working electrode
was successively polished with 1.0, 0.3 and 0.05 mm aluminaslurries (Buehler) on microcloth pads (Buehler). After each
polishing, the electrode was washed with water and sonicated
for 10 min in acetonitrile. Then, it was immersed into a hot
piranha solution (3:1, H2SO4, 30% H2O2) for 10 min, and
rinsed copiously with water. All potentials were reported
versus Ag/AgCl/KCl (3.0 M) reference electrode (BAS
Model MF-2078) at room temperature. The electrolyte solu-
tions were degassed with puriﬁed nitrogen for 10 min before
each experiment and bubbled with nitrogen during the
experiment.
Chromatographic analysis was carried out on an Agilent
6890N gas chromatography system equipped with 5973 series
mass selective detector, 7673 series autosampler and chemstation
(Agilent Technologies, Palo Alto, CA). HP-5 MS column
(30 m 0.25 mm, 0.25 mm) was used for separation. Splitless
injection was used and the carrier gas was helium at a ﬂow rate of
1 μg/mL. The injector and detector temperatures were 250 1C.
The MS detector parameters were transfer line temperature
280 1C, solvent delay 3 min and electron energy 70 eV. MS
was run in electron impact mode with selected ion monitoring
(SIM) for quantitative analysis.
2.3. Preparation of the standard and quality control (QC)
solutions
For the LSV method, the stock standard solution of diclofenac was
prepared in 0.1 M LiClO4/acetonitrile to a concentration of
100 μg/mL. For the GC–MS method, the stock solution of
diclofenac was prepared in methanol solution to a concentration
of 100 μg/mL. Standard solutions were prepared as 5–35 μg/mL
(5, 10, 15, 20, 25, 30 and 35 μg/mL) for LSV method and 0.25–
5 μg/mL (0.25, 1, 2, 3, 4 and 5 μg/mL) for the GC–MS method.
The QC samples were prepared by adding aliquots of standard
working solution of diclofenac to obtain the ﬁnal concentrations of
7.5, 17.5 and 32.5 μg/mL for the LSV method and 0.75, 2.5 and
4.5 μg/mL for the GC–MS method.
2.4. Procedure for pharmaceutical preparations
A total of 10 tablets of diclofenac (Diclomec, Dicloﬂam and
Voltaren) were accurately weighed and powdered. For the
LSV method, an amount of this powder corresponding to one
tablet diclofenac content was weighed and accurately trans-
ferred into a 100 mL calibrated ﬂask and 50 mL of 0.1 M
LiClO4/acetonitrile was added and then the ﬂask was sonicated
to 10 min at room temperature. The ﬂask was ﬁlled to volume
with 0.1 M LiClO4/acetonitrile. The resulting solutions in both
the cases were ﬁltered through Whatman ﬁlter paper no. 42
and suitably diluted to get a ﬁnal concentration within the
limits of linearity for the respective proposed method. For the
GC–MS method, an appropriate volume of ﬁltrate was diluted
further with methanol so that the concentration of diclofenac in
the ﬁnal solution was within the working range, and then
analyzed by GC–MS.
2.5. Data analysis
All statistical calculations were performed with the Statistical
Product and Service Solutions (SPSS) for Windows, version 10.0.
Correlations were considered statistically signiﬁcant if calculated P
values were 0.05 or less.
Fig. 1 (A) Cyclic voltammogram for the oxidation of 20 μg/mL
diclofenac and (B) blank in acetonitrile containing 0.1 M LiClO4 at Pt
disk electrode. Scan rate: 0.2 V/s.
Fig. 2 (A) Linear sweep voltammograms for different concentrations
of diclofenac in acetonitrile solution containing 0.1 M LiCIO4 (5, 10,
15, 20, 25, 30 and 35 μg/mL) and (B) mean calibration graph (n¼6).
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3.1. Method development and optimization
The electrochemical behavior of diclofenac was investigated at the
Pt disc electrode in anhydrous acetonitrile solution containing
0.1 M LiClO4 as the supporting electrolyte by using cyclic
voltammetry (CV).
Fig. 1 shows a typical cyclic voltammogram of 20 μg/mL
diclofenac recorded under these conditions for describing the scan
rate of 0.2 V/s. In the anodic sweep, two oxidation peaks were
seen at about potentials of 0.87 and 1.27 V, respectively.
To gain a deeper insight into the voltammetric waves, the effect of
scan rate on the anodic peak currents (İm) and peak potentials (Ep)
was studied in the range of 0.01–1 V/s the potential scan rates in
acetonitrile solution containing 20 μg/mL of diclofenac. Scan rate
dependency experiments showed that the peak currents for peak
varied linearly with the scan rate (ν), which points out the adsorption-
controlled process. However, the plots of logarithm of peak currents
versus logarithm of scan rates for 20 μg/mL concentration of
diclofenac displayed straight lines with 0.497 slope, which are close
to the theoretical value of 0.5 expected for an ideal diffusion-
controlled electrode process [29]. log Im–log ν curve is more eligible
for this aim; therefore, a diffusional process for peak should be
considered. These results suggested that the redox species were
diffusing freely from solution and not precipitating onto the electrode
surface. The reason for this behavior might be due to the solubility of
the intermediate species in acetonitrile or poor adherence of products
on the electrode surface.
The oxidation peak potential (E) for peaks shifted toward more
positive values with increasing scan rate. The relationship between
the peak potential and scan rate is described by the following
equation:
E¼ E00 þ RT=½ð1αÞnaF⌊0:78þ InðD1=2k1s Þ
0:5InRT=½ð1αÞnaFc þ RT=½ð1αÞnaF=2Invand from the variation of peak potential with scan rate αna can be
determined, where α is the transfer coefﬁcient and na is the number
of electrons transferred in the rate determining step. According to
this equation, the plots of the peak potentials versus ln ν for
oxidation peak show linear relationship. The slope indicates the
value of αna is 0.38 for peak. On the base of the above results, the
na is 1 and then the value of α is calculated to be 0.38, which is
reasonable for the most of irreversible electrode processes. Based
on the above discussions the oxidation process of diclofenac is
controlled by the diffusion step and one electron and one proton
are involved in the reaction.
During GC–MS method development, a capillary column
coated with 5% phenyl and 95% dimethylpolysiloxane was used
for separation. The injection port and detector temperature was set
to 250 1C. Different temperature programs were investigated to
give an optimum temperature program as follows: initial tempera-
ture was 150 1C, held for 1 min, increased to 220 1C at 20 1C/min,
held for 1 min, and ﬁnally to 300 1C at 10 1C/min with a ﬁnal
maintenance of 1.0 min. The injector volume was 1 μL in
splitless mode.
3.2. Method validation
To ensure optimization of the methods in light of the standardiza-
tion rules, the developed methods were validated in terms of
speciﬁcity, linearity, precision, accuracy, LOD, LOQ, recovery
and the stability effect which was investigated by analyzing the
pure diclofenac solution and drug samples [30].
3.2.1. Speciﬁcity
All the solutions were scanned from 0.5 to 1.5 V and checked for
change in the peaks at respective potentials (Fig. 2).
In a separate study, the speciﬁcity of the method was
investigated by observing interferences between diclofenac and
the excipients. For GC–MS, electron impact mode with selected
ion monitoring (SIM) was used for quantitative analysis (m/z 214
for diclofenac).
Fig. 4 (A) GC–MS chromatograms of diclofenac (0.25, 0.5, 1, 2, 3, 4
and 5.0 μg/mL) [Selected ion monitoring (SIM) mode, m/z 214 for
diclofenac] and (B) mean calibration graph (n¼6).
Fig. 3 (A) MS spectra of diclofenac and (B) chemical structure of diclofenac.
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retention time of diclofenac in GC–MS method was approximately
5.9 min with good peak shape (Fig. 4).
3.2.2. Linearity
For the LSV and GC–MS measurements, the solutions were
prepared by dilution of the stock solution of diclofenac to reach
a concentration range of 5–35 μg/mL (5, 10, 15, 20, 25, 30 and
35 μg/mL) and 0.25–5 μg/mL (0.25, 0.5, 1, 2, 3, 4 and 5 μg/mL),
respectively. Calibration curves were constructed for diclofenac
standard by plotting the concentration of diclofenac versus
voltammogram and peak area response. The calibration curve
constructed was evaluated by its correlation coefﬁcient. The
correlation coefﬁcients (r) of all the calibration curves were
consistently greater than 0.99. The regression equations were
calculated from the calibration graphs, along with the standard
deviations of the slope and intercept on the ordinate. The results
are shown in Table 1.3.2.3. Precision and accuracy
The precision of the LSV and GC–MS methods was determined
by repeatability (intra-day) and intermediate precision (inter-day).
Repeatability was evaluated by analyzing QC samples six times
per day at three different concentrations. The intermediate preci-
sion was evaluated by analyzing the same samples once daily for
two days. The RSD of the predicted concentrations from the
regression equation was taken as precision. The accuracy of this
analytic method was assessed as the percentage relative error. For
all the concentrations studied, intra- and inter-day relative standard
deviation values were r4.62% and for all concentrations of
diclofenac the relative errors were r6.29%. These results are
given in Table 2.
3.2.4. LOD and LOQ
For LSV measurements, LOD and LOQ of diclofenac were
determined using calibration standards. The LOD and LOQ values
were calculated as 3.3 σ/S and 10 σ/S, respectively, where S is the
slope of the calibration curve and σ is the standard deviation of
y-intercept of regression equation (n¼6) [31].
For GC–MS measurements, the LOD and LOQ of diclofenac
were determined by injecting progressively low concentration of
the standard solution under the chromatographic conditions. The
lowest concentration assayed was regarded as LOQ, where the
signal/noise ratio was at least 10:1. The LOD was deﬁned as a
signal/noise ratio of 3:1. The LOD and LOQ for LSV were 1.6
and 4.8 μg/mL, for GC–MS 0.05 and 0.15 μg/mL, respectively.
Among the two methods, GC–MS was more sensitive than LSV
(Table 1).
3.2.5. Recovery
To determine the accuracy of the LSV and GC–MS methods
and to study the interference of formulation additives, the
recovery was checked at three different concentration levels.
Analytical recovery experiments were performed by adding
known amount of pure drugs to pre-analyzed samples of
commercial dosage forms. The recovery values were calcu-
lated by comparing concentration obtained from the spiked
samples with actual added concentrations. These values are
also listed in Table 3.
3.2.6. Ruggedness
Determination of diclofenac using both the LSV and GC–MS
methods was carried out by a different analyst on the same
instrument with the same standard (Table 4).
The results showed no statistical differences between
different operators, suggesting that the developed method
was rugged.
Table 2 Precision and accuracy of diclofenac.
Method Added (mg/mL) Intra-day Inter-day
Found7SDa (mg/mL) Precision
(% RSD)b
Accuracyc Found7SDa (mg/mL) Precision
(% RSD)b
Accuracyc
LSV 7.5 7.8870.23 2.91 5.06 7.2970.19 2.61 2.80
17.5 18.1370.30 1.65 3.60 18.6070.32 1.72 6.29
32.5 33.4471.47 4.39 2.89 33.0271.59 4.62 1.60
GC–MS 0.75 0.7770.03 3.89 2.67 0.7470.02 2.30 1.33
2.5 2.4870.09 3.62 2.08 2.4970.06 2.65 0.40
4.5 4.4770.07 1.56 1.17 4.4870.05 1.21 0.44
aSD: standard deviation of six replicate determinations.
bRSD: relative standard deviation, average of six replicate determinations.
cAccuracy: (found–added)/added  100.
Table 1 Linearity of diclofenac.
Method Range (mg/mL) LR Sa Sb R LOD (mg/mL) LOQ (mg/mL)
LSV 5–35 y¼0.0886x0.240 0.043 0.012 0.992 1.6 4.8
GC–MS 0.25–5 y¼732.34x40.907 11.096 2.081 0.999 0.05 0.15
Based on three calibration curves, LR: linear regression, Sa: standard deviation of intercept of regression line, Sb: standard deviation of slope of
regression line, R: coefﬁcient of correlation, x: diclofenac concentration, LOD: limit of detection, LOQ: limit of quantiﬁcation.
Table 3 Recovery of diclofenac in pharmaceutical preparations.
Commercial preparation Method n Found (mg) (Mean7SD) Recovery RSDa (%) Conﬁdence interval
Diclomec (100 mg/tablet) LSV 6 99.770.5 99.7 0.5 98.0–101.2
GC–MS 6 101.171.0 101.1 1.0 99.0–102.5
Dicloﬂam (50 mg/tablet) LSV 6 49.471.3 98.8 2.6 48.3–51.2
GC–MS 6 50.571.5 101.0 3.1 49.8–51.3
Voltaren (75 mg/tablet) LSV 6 74.872.1 99.7 2.8 74.7–75.9
GC–MS 6 74.772.3 99.6 3.1 74.3–76.1
SD: standard deviation of six replicate determinations, RSD: relative standard deviation.
aAverage of six replicate determinations.
Table 4 The results of analyses of diclofenac by a different analyst.a
Method Added (mg/mL) Found (mg/mL) (Mean7SD) Recovery RSDa (%)
LSV 5 4.970.1 98 2.0
15 14.870.2 99 1.3
35 35.470.7 101 1.9
GC–MS 0.5 0.570.01 100 2.0
15 14.870.1 99 0.6
35 34.070.3 97 0.9
aMean measurements of six replicate determinations.
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Stability studies indicated that the samples were stable when kept
at room temperature, þ4 1C and 20 1C for 24 h (short-term) and
20 1C for 72 h (long-term).
The results are given in Table 5, where the percent ratios were
within the acceptance range of 90–110%.3.3. Comparison of the methods
Birajdar et al. [10] developed a reverse phase HPLC method for
the simultaneous determination of rabeprazole and diclofenac in
tablet. The method was based on HPLC separation of both drugs
in reverse phase mode using Phenomenox C18 column with Waters
Table 5 Stability of diclofenac in solution at different temperatures (Recovery7RSD, %).
Method Added (mg/mL) Room temperature 4 1C 20 1C
8 h 24 h 24 h 72 h 24 h 72 h
LSV 0.75 101.174.46 99.272.94 102.373.84 98.673.15 101.274.12 99.473.87
2.5 101.875.02 101.473.64 98.275.14 101.973.84 99.473.47 99.773.09
4.5 98.573.17 99.274.76 98.274.06 97.473.75 97.875.05 101.274.64
GC–MS 1.0 99.375.18 102.273.29 99.773.16 101.274.51 101.172.96 98.673.55
3.0 101.374.74 101.474.47 102.174.08 99.473.71 98.671.84 98.972.44
5.0 102.673.44 98.574.60 101.473.14 97.873.01 99.773.49 97.872.27
RSD: Relative standard deviation of six replicate determinations.
Fig. 5 Linear sweep voltammogram of Voltaren tablet solution
containing 15 and 30 μg/mL of diclofenac.
Fig. 6 GC–MS chromatogram of Voltaren tablet solution containing
1 and 4 μg/mL of diclofenac.
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trile and 50 mM ammonium acetate buffer (pH 3.6) (60:40, v/v) at
ﬂow rate of 1 mL/min. Detection wavelength used was at 254 nm.
Linearity was obtained in the concentration range of 1.0–3.2 μg/mL
for rabeprazole and 6.0–16.0 μg/mL for diclofenac.
Sastry et al. [13] described a spectrophotometric method for the
determination of diclofenac sodium in bulk samples and pharma-
ceutical preparations with p-N,N dimethylphenylenediamine as a
solvent and having maximum absorbance at 670 nm. The reaction
was sensitive enough to permit the determination of 2.0–24 μg/mL.
Agrawal et al. [14] described two methods for the determination
of diclofenac. In the ﬁrst method, diclofenac reduced iron(III) to
iron(II) having a maximum absorbance at 520 nm. The reaction
obeys Beer’s law for concentrations of 10–80 μg/mL. In the
second method, diclofenac was treated with methylene blue in
the presence of phosphate buffer (pH 6.8) and the complex was
extracted with chloroform. The complex had a maximum absor-
bance at 640 nm and linearity was in the range of 5–40 μg/mL.
Marcela et al. [15] developed a spectroﬂuorometric method for the
determination of diclofenac. The method was based on its reaction
with cerium (IV) in an acidic solution and measurement of theﬂuorescence of the Ce(III) ions produced. The absorbance was
measured at 356 and 250 nm with double distilled water as solvent.
Thongchai et al. [17] developed a high-performance thin layer
chromatographic method for the determination of diclofenac
sodium in pharmaceutical formulations. The drug was extracted
from the sample and then various aliquots of this solution were
spotted automatically by means of Camag Linomat IV on a silica
gel 60 F254 aluminum plate, using a mixture of toluene: ethyl
acetate: glacial acetic acid (60:40:1, v/v/v) as mobile phase. The
spot areas were quantiﬁed by densitometry at 282 nm. Linear
calibration curve was obtained over the range of 5–80 μg/mL.
For LSV and GC–MS measurements, calibration curves were
linear over the concentration range of 5–35 and 0.25–5 μg/mL for
diclofenac, which is as good as or superior to that reported in other
papers [10,13–15,17].
Also, LSV and GC–MS methods were applied for the determi-
nation of diclofenac in three commercial tablets (Figs. 5 and 6).
The results show the high reliability and reproducibility of two
methods. The results were statistically compared using the F-test.
At 95% conﬁdence level, the calculated F-values do not exceed
Table 6 Comparison of the proposed and reported methods for determination of diclofenac.
Method Recovery (Mean7SD, %) Conﬁdence limits P value F-test
Ofﬁcial method
(USP XXIV)
(HPLC)
99.470.39 99.372.18 0.342 Fc¼1.72
LSV 99.772.63 99.173.86 Ft¼3.00
GC–MS 100.277.63 100.173.97
SD: standard deviation of six replicate determinations, Fc: calculated F-value, Ft: tabulated F-value, Ho hypothesis: no statistically signiﬁcant
difference exists between three methods, Ft4Fc: Ho hypothesis is accepted (P40.05).
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difference between LSV and GC–MS methods.
USP XXIV has recommended HPLC method for analysis of
diclofenac in pure and dosage forms (tablet). The method
recommends use of a mobile phase of methanol and phosphate
buffer (pH 2.5) at a ﬂow rate of 1 μg/mL.
Also, the proposed LSV and GC–MS methods were compared
with the HPLC method of USP XXIV [32]. There was no
signiﬁcant difference between the three methods with respect to
mean values and standard deviations at the 95% conﬁdence level
(Table 6). Therefore, this is suggested that the two methods are
equally applicable.4. Conclusion
In the present work, two new methods have been developed and
validated for routine determination of diclofenac in pharmaceutical
preparations. Linearity range, precision, accuracy, LOD and LOQ
are suitable for the quantiﬁcation of diclofenac in pharmaceutical
preparations. The sample recoveries in three formulations were in
good agreement with their respective label claims. No extraction
procedure is involved. According to the statistical comparison of
the results, there is no signiﬁcant difference between LSV and
GC–MS methods. The proposed methods can be used for the
routine quality control analysis of diclofenac in pharmaceutical
preparations in a total time of 6 min.Acknowledgments
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